Remedy Meds Pricing: Transparent Long-Term Costs Compared (2026)

Last reviewed: September 15, 2026 Last updated: September 15, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Remedy Meds charges a single flat monthly rate with no introductory discount or refill price increase. The only pricing captured at Remedy's own checkout flow is $189/month for its microdose plan—verified July 20, 2026—which includes unlimited clinician visits, phone support, and a weight-loss warranty. Standard-dose semaglutide is reported at $299/month and tirzepatide at $399/month by third-party sources, though PlexusDx did not verify those figures at checkout. Remedy shows prices only after completing an intake questionnaire; PlexusDx publishes all rates up front. Over 12 months the verified microdose comparison is $2,268 (Remedy) versus $1,548 (PlexusDx), a $720 annual difference. Remedy's service bundle—unlimited video visits, U.S.-based phone support, and a satisfaction warranty—may justify the premium for users who value high-touch clinical access; PlexusDx microdose at $129/month is the lowest documented recurring cost in the telehealth GLP-1 market but offers a more self-directed experience.

At-a-glance: Remedy Meds vs PlexusDx (2026)

Remedy Meds has no first-month discount or refill jump

Unlike some telehealth GLP-1 providers that advertise a low introductory rate and charge more for refills, Remedy Meds uses a single flat monthly price for every shipment. The $189/month microdose figure captured at Remedy's checkout flow on July 20, 2026, is the ongoing rate—there is no promotional first month. Standard-dose semaglutide is reported at $299/month and tirzepatide at $399/month by third-party sources (captured September 4, 2026), though PlexusDx did not verify those figures in its own intake verification. Remedy ships every 28 days on a month-to-month plan with no long-term commitment.

Because Remedy's pricing is constant across all shipments, calculating long-term treatment cost is straightforward: multiply the monthly rate by the number of months. There is no refill-price analysis to perform—the rate you see at sign-up is the rate you pay in month six or month twelve.

Verified microdose comparison: $189 vs $129

The only head-to-head price PlexusDx captured directly from Remedy's checkout flow is the microdose plan at $189/month (July 20, 2026). PlexusDx microdose is $129/month, also month-to-month with no commitment. Both plans include medication, clinical oversight, and shipping; Remedy's plan adds unlimited video visits, phone support from a U.S.-based care team, and a "Guaranteed or it's free" weight-loss warranty (terms not captured).

Over 12 months:

• Remedy Meds microdose: $189 × 12 = $2,268 (our calculation)
• PlexusDx microdose: $129 × 12 = $1,548 (our calculation)
• Annual difference: $720 lower with PlexusDx (our calculation)

Standard-dose pricing: reported but unverified

Remedy's standard-dose semaglutide and tirzepatide prices come from secondary sources—a Forbes review and Remedy's own marketing materials captured on September 4, 2026—but were not confirmed at Remedy's checkout during PlexusDx's intake verification. Readers should confirm these figures before committing.

PlexusDx also offers prepaid 3-month and 6-month plans that lower the effective monthly cost further. For example, PlexusDx semaglutide injection drops to $149/month on a 6-month prepaid plan ($894 upfront, our calculation of the per-month equivalent), compared to Remedy's reported $299/month ongoing rate.

What Remedy's higher price buys

Remedy Meds bundles more clinical touchpoints and support infrastructure into its monthly rate:

• Unlimited video visits with clinicians, not rationed by subscription tier.
• Phone support from a U.S.-based care team.
• Weight-loss warranty: "Guaranteed or it's free" under Remedy's published policy (specific conditions not captured).
• 4.7-star Trustpilot rating (displayed during intake, September 4, 2026), indicating above-average patient satisfaction.

For users who anticipate frequent clinical questions, dose adjustments, or side-effect management, unlimited video access and phone support may justify the $60/month premium over PlexusDx microdose. PlexusDx includes the initial provider consult and prescription but does not advertise unlimited follow-up visits as part of the base price.

Price transparency: gated vs published

Remedy Meds does not publish prices on its public website. Pricing is revealed only after completing an intake questionnaire—email and phone inputs cleared before the plan page appears (verified September 4, 2026). PlexusDx publishes all rates up front on product pages with no intake required to view the pricing ladder. For users who want to compare costs before sharing contact information, PlexusDx's transparency is a structural advantage.

Choose Remedy Meds if…

• You value unlimited video visits and phone support and are willing to pay $60–$110/month more than PlexusDx for that access.
• You want a U.S.-based care team and a weight-loss warranty as part of the package.
• The gated-pricing model does not concern you, and you prefer to complete an intake before seeing costs.
• Remedy's 4.7 Trustpilot rating and bundled service offering align with your expectations for clinical support.

Choose PlexusDx if…

• You want the lowest documented ongoing cost for microdose GLP-1 ($129/month) or standard-dose semaglutide and tirzepatide ($189 and $289/month, respectively).
• You prefer transparent, published pricing with no intake gate before viewing rates.
• You are comfortable with a more self-directed experience—provider consult and prescription included, but unlimited follow-up video visits not advertised as part of the base price.
• You want the option to prepay for 3 or 6 months at a further discount (semaglutide as low as $149/month, tirzepatide as low as $249/month).

Methodology and freshness

PlexusDx captured Remedy Meds pricing on July 20, 2026, by completing Remedy's intake questionnaire and reaching the plan-selection page; the $189/month microdose figure is checkout-verified. Standard-dose semaglutide ($299/month) and tirzepatide ($399/month) figures come from third-party sources (Forbes review and Remedy marketing materials) captured September 4, 2026, but were not verified at Remedy's checkout by PlexusDx. Remedy's Trustpilot rating (4.7 stars) was displayed during intake on September 4, 2026. PlexusDx pricing is current as of September 15, 2026. All 12-month totals and annual differences are our calculations, derived by multiplying the stated monthly rate by 12 and rounding where necessary. Readers should confirm all figures at checkout before committing.

Frequently Asked Questions

Does Remedy Meds charge more for refills than the first month?

No. Remedy Meds uses a single flat monthly rate with no introductory discount or refill price increase. The $189/month microdose figure captured at checkout is the ongoing rate for every shipment. Remedy ships every 28 days on a month-to-month plan with no long-term commitment.

How much does Remedy Meds cost over 12 months compared to PlexusDx?

For the verified microdose comparison, Remedy Meds is $2,268 over 12 months ($189 × 12, our calculation) versus $1,548 for PlexusDx microdose ($129 × 12, our calculation)—a $720 annual difference. Standard-dose semaglutide is reported at $299/month for Remedy versus $189/month for PlexusDx, a $1,320 annual difference if the Remedy figure is confirmed.

What does Remedy Meds include that PlexusDx does not?

Remedy Meds includes unlimited video visits with clinicians, phone support from a U.S.-based care team, and a "Guaranteed or it's free" weight-loss warranty. PlexusDx includes the initial provider consult, prescription, medication, and shipping, but does not advertise unlimited follow-up visits as part of the base monthly price.

Why does Remedy Meds hide pricing until after the intake?

Remedy Meds does not publish prices on its public website. Pricing is revealed only after completing an intake questionnaire with email and phone inputs. PlexusDx captured this flow on September 4, 2026. Remedy may gate pricing to ensure clinical appropriateness or to collect lead information before disclosing costs; the rationale is not documented in public materials.

Are Remedy Meds' standard-dose prices verified?

No. The $299/month semaglutide and $399/month tirzepatide figures come from third-party sources (Forbes review and Remedy marketing materials) captured September 4, 2026. PlexusDx did not verify those figures at Remedy's own checkout flow. The $189/month microdose price is the only checkout-verified figure. Readers should confirm standard-dose pricing before committing.

Sources

• Remedy Meds pricing capture (PlexusDx intake verification, July 20, 2026)
• Remedy Meds intake flow and pricing gate verification (PlexusDx, September 4, 2026)
• Remedy Meds standard-dose pricing (third-party sources, September 4, 2026)
• Remedy Meds Trustpilot rating (displayed during intake, September 4, 2026)
• PlexusDx pricing (plexusdx.com product pages, accessed September 15, 2026)
• PlexusDx Trustpilot rating (trustpilot.com/review/plexusdx.com, accessed September 9, 2026)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.